A first look at the phase 3 data with Eli Lilly's oral GLP-1 agonist orforglipron reveals encouraging blood sugar control data in patients with type 2 diabetes, and a side-effect profile free of the ...
That revamp was designed to ensure the biotech had resources to deliver three key trial readouts, namely interim data from the phase 2 portion of its antibody-drug conjugate (ADC) MGC018 in prostate ...
Abstract: This paper introduces a new class of fractionalorder phase-locked loops (FOPLLs) of complex orders, extending the traditional integer-order or even the real-order models. By incorporating ...
Abstract: In power systems with high renewable energy penetration, rapid and accurate separation of positive-and negative-sequence voltage components under asymmetric faults is crucial for converter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results